Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Intimation For Change In Address And Contact Details Of Registrar And Share Transfer Agent (RTA)

 We would like to inform that our Registrar and Share Transfer Agent i.e. Universal Capital Securities Private Limited, has shifted its Office to following address with effect from 01st September 2020: Universal Capital Securities Private Limited. Unit: Bliss GVS Pharma Limited C 101, 247 Park, LBS Road, Vikhroli West, Mumbai - 400083. Tel Nos. : (022) 28207203-05 Fax No. : (022) 28207207 Email id : [email protected] Website: www.unisec.in. Accordingly, all the future communications addressed to our RTA must be communicated to the above new address only. You are requested to update the abovementioned details on your website and records. This is for your kind information and for dissemination to all the concerned.
04-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Reg. 34 (1) Annual Report

 Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed Notice convening the 35th AGM and the Annual Report of the Company for the financial year 2019-20. The Annual Report of the Company is also being sent through electronic mode to those Members whose e-mail addresses are registered with the Company/Registrars and Share Transfer Agent/Depositories. The Annual Report for the financial year 2019-20 is also being made available on the website of the Company at http://www.blissgvs.com/investors/financials/annual-reports-2/ . This is for your information and records.
03-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Notice Of The 35Th AGM Of Bliss GVS Pharma Limited Scheduled To Be Held On Friday, September 25, 2020 At 09:30 A.M. Through Video Conference/Other Audio-Visual Means.

 Pursuant to Regulation 30 read with Para A, Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 35th AGM of Bliss GVS Pharma Limited scheduled to be held on Friday, September 25, 2020 at 09:30 a.m. (IST) through Video Conference/Other Audio-Visual Means. The said Notice forms part of the 35th Annual Report of the Company for the Financial Year 2019-2020. The Notice of the 35th AGM of the Company for the financial year 2019-2020 is also being made available on the website of the Company at http://www.blissgvs.com/investors/shareholder-information/annual-general-meeting/ . This is for your information and records.
03-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 read with Schedule III Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and in compliance with the General Circular dated May 5, 2020 read with General Circulars dated April 8, 2020 and April 13, 2020 issued by the Ministry of Corporate Affairs and SEBI Circular dated May 12, 2020, we enclose clippings of newspaper advertisements published for giving Notice of the 35th Annual General Meeting of the Company to be held on Friday, September 25, 2020, at 09:30 a.m. (IST) through Video Conferencing / Other Audio Visual Means only, procedure for registering e-mail addresses, details of final dividend and book closure date, manner of payment of dividend and tax on dividend if declared at the AGM. The notice was published in Free Press Journal and Navshakti- Mumbai newspapers on August 30, 2020.
02-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the quarter ended June 30, 2020 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on August 22, 2020 .
28-08-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Outcome of Board Meeting (AGM on Sept 25, 2020)

 Bliss GVS Pharma Ltd has informed BSE about Outcome of Board Meeting held on August 20, 2020.
20-08-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Intimation Of Book Closure In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 Pursuant to Section 91 of the Companies Act, 2013 ('Act'') and applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with our intimation submitted to you w.r.t. Final Dividend on June 16, 2020, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 19th September, 2020 to Friday, 25th September, 2020 (both the days inclusive) for taking on record of the members of the Company for the purpose of holding 35th Annual General Meeting of the Company for financial year ended 31st March, 2020. This is for your information and record.
20-08-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Outcome Of Board Meeting Held On Thursday, August 20, 2020

 We would like to inform you that Board Meeting of the Company was held today i.e. on Thursday, August 20, 2020 at registered office of the Company. In pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved as attached.
20-08-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company scheduled to be held on Thursday, August 20, 2020 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2020 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on August 13, 2020. Kindly take the same on record.
14-08-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2020

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2020 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2020. Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from July 01, 2020 and shall remain closed till 48 hours after the announcement of the Financial Results of the Company for the quarter ended June 30, 2020.
12-08-2020
Next Page
Close

Let's Open Free Demat Account